Lexaria Bioscience Corp (LEXX)
2.16
-0.04
(-1.82%)
USD |
NASDAQ |
Nov 21, 16:00
2.17
+0.01
(+0.46%)
Pre-Market: 20:00
Lexaria Bioscience Price to Book Value: 3.374 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 3.374 |
| November 20, 2024 | 3.436 |
| November 19, 2024 | 3.389 |
| November 18, 2024 | 3.264 |
| November 15, 2024 | 3.139 |
| November 14, 2024 | 3.311 |
| November 13, 2024 | 3.530 |
| November 12, 2024 | 3.592 |
| November 11, 2024 | 3.608 |
| November 08, 2024 | 3.686 |
| November 07, 2024 | 3.624 |
| November 06, 2024 | 3.420 |
| November 05, 2024 | 3.483 |
| November 04, 2024 | 3.561 |
| November 01, 2024 | 3.624 |
| October 31, 2024 | 3.358 |
| October 30, 2024 | 3.545 |
| October 29, 2024 | 3.686 |
| October 28, 2024 | 3.936 |
| October 25, 2024 | 4.139 |
| October 24, 2024 | 4.264 |
| October 23, 2024 | 4.217 |
| October 22, 2024 | 4.311 |
| October 21, 2024 | 4.295 |
| October 18, 2024 | 4.311 |
| Date | Value |
|---|---|
| October 17, 2024 | 4.420 |
| October 16, 2024 | 4.483 |
| October 15, 2024 | 4.483 |
| October 14, 2024 | 4.779 |
| October 11, 2024 | 4.842 |
| October 10, 2024 | 4.779 |
| October 09, 2024 | 4.647 |
| October 08, 2024 | 4.779 |
| October 07, 2024 | 4.826 |
| October 04, 2024 | 4.982 |
| October 03, 2024 | 5.170 |
| October 02, 2024 | 5.154 |
| October 01, 2024 | 4.936 |
| September 30, 2024 | 4.764 |
| September 27, 2024 | 4.717 |
| September 26, 2024 | 4.639 |
| September 25, 2024 | 4.873 |
| September 24, 2024 | 4.873 |
| September 23, 2024 | 4.936 |
| September 20, 2024 | 5.092 |
| September 19, 2024 | 4.920 |
| September 18, 2024 | 5.029 |
| September 17, 2024 | 5.092 |
| September 16, 2024 | 5.264 |
| September 13, 2024 | 5.357 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.9326
Minimum
May 10 2023
22.78
Maximum
Feb 09 2021
5.306
Average
3.361
Median
Price to Book Value Benchmarks
| Aurinia Pharmaceuticals Inc | 3.236 |
| Edesa Biotech Inc | 2.390 |
| Xenon Pharmaceuticals Inc | 3.803 |
| ESSA Pharma Inc | 0.606 |
| ImmunoPrecise Antibodies Ltd | 0.41 |
Price to Book Value Related Metrics
| PS Ratio | 54.89 |
| Price | 2.16 |
| Earnings Yield | -20.37% |
| Market Cap | 34.15M |